No Data
No Data
Express News | Evaxion Biotech A/S Files for Stock Shelf of up to $50 Mln- SEC Filing
Evaxion to Present at Numerous Upcoming Conferences
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
Evaxion Biotech Extends Phase 2 Trial for Cancer Vaccine EVX-01
Express News | Evaxion Biotech A/S: Trial Has Been Extended by an Additional Year to Collect Three-Year Clinical Outcome Data
Express News | Evaxion Extends Phase 2 Trial With Personalized Cancer Vaccine Evx-01 to Further Enhance Clinical Data Package